期刊文献+

多层螺旋CT预测胃肠间质瘤危险度的临床价值 被引量:1

The Value of Multi-slice CT Predicted the Risk Stratification of Gastrointestinal Stromal Tumor
下载PDF
导出
摘要 目的 对照病理结果,探讨胃肠间质瘤多层螺旋CT表现与其危险度的相关性.方法 回顾性分析经病理证实胃肠间质瘤36例的多层螺旋CT表现,对照病理分级,采用SPSS17.0统计软件进行Fishers精确检验,分析胃肠间质瘤多层螺旋CT表现与GIST危险度有无统计学差异.结果 胃肠间质瘤多层螺旋CT表现:肿瘤大小、形态、生长方式、强化形式、肿瘤内坏死与GIST危险度有统计学意义(P〈0.05).结论 胃肠间质瘤多层螺旋CT表现:肿瘤大小、形态、生长方式、强化形式、肿瘤内坏死可以预测其危险度.胃肠间质瘤浸润邻近结构及器官、周围淋巴结肿大和转移即提示肿瘤高危险度. Objective To analyze the correlation between radiological features and risk stratification of GIST. Methods The CT images of 36 surgically treated patients with histologically and immunohistochemically confirmed GIST were retrospectively analyzed. The Fisherg exact tests were used to assess any possible relationships between risk stratification of GIST and turnout size, contour, growth status, enhancement pattern, degree of enhancement, presence of necrosis, calcificationsor and ulcer. Results The size, contour, growth status, enhancement pattern, presence of necrosis were all associated with risk stratification of GIST in statistical analyses ( P 〈 0.05 ). Conclusion The CT features of GIST: the size, contour, growth status, enhancement pattern, presence of necrosis are helpful in identifying predictors the risk stratification of GIST. It suggestes that GIST is high-risk when GIST invasion of the mesentery or adjacent organs, lymphadenopathy and metastasis.
出处 《潍坊医学院学报》 2012年第2期87-89,共3页 Acta Academiae Medicinae Weifang
关键词 胃肠间质瘤 X线计算机 体层摄影术 病理学 Gastrointestinal Stromal Tumors X-ray computed Tomography Pathology
  • 相关文献

参考文献7

  • 1Kim HC, Lee JM, Kim KW, et al. Gastrointestinal stromal tumors of the stomach : CT findings and prediction of malignancy [ J ]. A JR,2004,183 (4) :893 - 898.
  • 2Fletcher CD, Berman JJ, Corfoss C, et al. Diagnosis of gastrointestinal stromal tumors : A consensus approach [ J ]. Hum Patho, 2002,33 ( 5 ) : 459 - 465.
  • 3中国胃肠道间质瘤诊断治疗共识[J].中华病理学杂志,2009,38(10):697-702. 被引量:101
  • 4Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c- kit in human gastrointestinal stromal tumors [ J]. Science, 1998,279 (5350) :577 -580.
  • 5Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor[ J]. Hum Pathol,2008,39(10) :1411 - 1419.
  • 6Ulusan S, Koc Z, Kayaselcuk F. Gastrointestinal stromal tumours : CT findings[J]. Br J Radiol,2008,81 (968) :618 -623.
  • 7Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors:recent advances in understanding of their biology [ J ]. Hum Pathol, 1999,30(10) : 1213 - 1220.

二级参考文献29

  • 1贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 2詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 3Casali PG, Jost L, Reichardt P, et al. Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol, 2009, 20 Suppl 4:64-67.
  • 4Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002, 33(5):459-465.
  • 5Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol, 2005, 29( 1 ) : 52-68.
  • 6Miettinen M, Lasota J. KIT ( CD117 ) : a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol, 2005, 13 (3) :205-220.
  • 7Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol, 2004, 22(18) : 3813-3825.
  • 8Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med, 2006, 130(10) : 1466-1478.
  • 9Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 2008, 39 (10): 1411-1419.
  • 10DeMatteo RK, Owzar KR, Maki R, et al. Adjuvant imatinib mesylate increases recurrence free survival (RFS) in patients with completely resected localized primary gastrointestinal stromal tumor (GIST): North American Intergroup phase Ⅲ trial ACOSOG Z9001. ASCO Annual Meetings Proceedings Part Ⅰ. J Clin Oncol, 2007, 25(18 Suppl) : 10079.

共引文献100

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部